Total Funding
83
19
Total FundingSeed raised
Growth Score 83 in past quarter
-5 pts
Heat Score 19 in past quarter
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
315573
Beagle Bioproduct markets cyanobacterial toxins for research applications and for the monitoring and mitigation of harmful algal blooms.
- Eric P. Roy: Co-Founder and Executive Director
- Stephanie A. Smith: Co-founder, CSO, and COO
About the Company
Beagle Bioproducts, Inc. was founded in January 2012 with the intent to emerge as the most reliable domestic supplier of cyanobacterial toxins for research and for the monitoring and mitigation of harmful algal blooms (HABs). Our products will be available consistently and affordably, and we will develop a new line of lower-grade toxin products for
research applications that don’t require high-purity (and high-cost) toxins. Upon establishing ourselves in the U.S. market, we intend to expand to global markets so that these products will be available to people studying and mitigating HABs worldwide.
Women Founded
